Pulse oximeter integration for evaluating and updating a drug administration schedule using effectiveness rating

• US 10,811,130 B2
• Filed: 11/21/2016
• Issued: 10/20/2020
• Est. Priority Date: 11/23/2015
• Status: Active Grant

• Current Assignee: Koninklijke Philips N.V.
• Original Assignee: Koninklijke Philips N.V.
• Inventors: Cronin, John, Philbin, Steven Matthew
• Primary Examiner(s): Chng, Joy
• Application Number:
  US15/776,123
• Publication Number:
  US 20180336962A1
• Time in Patent Office: 1,429 Days
• Field of Search: 705 2- 3
• CPC Class Codes: A61B 5/14552 Details of sensors specially adapted therefor
• CPC Class Codes: A61B 5/4839 combined with drug delivery
• CPC Class Codes: A61B 5/4848 Monitoring or testing the effects of treatment, e.g. of medication
• CPC Class Codes: A61B 5/742 using visual displays A61B5/339 takes precedence
• CPC Class Codes: A61M 5/1407 Infusion of two or more substances
• CPC Class Codes: G16H 10/60 for patient-specific data, e.g. for electronic patient records
• CPC Class Codes: G16H 20/17 delivered via infusion or injection
• CPC Class Codes: G16H 40/63 for local operation
• CPC Class Codes: G16H 50/30 for calculating health indices; for individual health risk assessment

Abstract

Method of scheduling drug administration using a pulse-oximetry integrated intravenous fluid system comprising retrieving from at least one network server database via an intravenous pump unit patient-related and drug-related data and information. The retrieved data are displayed on the intravenous pump unit interface and then a patient'"'"'s pulse oximetry data is acquired. Using the pulse oximetry data, patient history, patient condition, diagnosis, and information relating to the one or more drugs, a medical personnel determines a schedule of drug administration. During the set duration of a drug administration schedule, one or more observed effects of the one or more drugs administered to the patient via the intravenous pump unit interface is inputted into the IV pump unit, and the patient record stored in the at least one network database is updated.

Claims

1. A method of scheduling drug administration using a pulse-oximetry integrated intravenous fluid system, the method comprising:

retrieving patient data from at least one database over a communication network, the patient data comprising patient history, patient condition, diagnosis, and information relating to one or more drugs to be administered to a patient;

displaying the retrieved patient data on a screen of an intravenous pump unit interface;

monitoring pulse oximetry data from the patient via a pulse oximeter;

formulating a schedule of drug administration based on the pulse oximetry data, patient history, patient condition, diagnosis, and information relating to the one or more drugs;

monitoring one or more effects of the one or more drugs administered to the patient via the intravenous pump unit;

calculating an effectiveness rating for the set drug administration schedule based on the monitored effects, the effectiveness rating indicating the efficacy of the one or more administered drugs and/or extent of improvement in the patient'"'"'s medical condition by the drug administration;

displaying a user interface allowing a user to update the calculated effectiveness rating; and

updating a patient record for the patient stored in the at least one database based on the monitored effects and calculated or updated effectiveness rating.

2. The method of claim 1, wherein formulating the schedule of drug administration comprises selecting a drug administration schedule from a plurality of drug administration schedules.

3. The method of claim 2, wherein selecting the drug administration schedule is based on drug administration schedules previously used for patients with similar medical profiles.

4. The method of claim 1, wherein the one or more drugs are associated with at least one genetic factor.

5. The method of claim 4, wherein the genetic factor includes a circadian gene.

6. The method of claim 1, further comprising modifying the set drug administration schedule based on at least one of the pulse oximetry data, one or more observed patient responses to the set drug administration schedule, the calculated effectiveness rating, and an effectiveness rating inputted by a medical personnel.

7. The method of claim 1, wherein the intravenous pump unit can control one or more drug delivery rates, at least one environment parameter, dosing frequency, and amount of drug delivered over the duration of the treatment period.

15. A non-transitory computer-readable storage medium, having embodied thereon a program executable by a processor to perform the method of claim 1.

8. A system of scheduling drug administration using a pulse-oximetry integrated intravenous fluid system, the system comprising:

at least one database that stores patient data comprising patient history, patient condition, diagnosis, and information relating to one or more drugs to be administered to a patient;

an intravenous pump unit interface that displays the retrieved patient data on a screen;

a pulse oximeter that monitors pulse oximetry data from the patient;

a processor that executes instructions stored in memory, wherein execution of the instructions by the processor;

formulates a schedule of drug administration based on the pulse oximetry data, patient history, patient condition, diagnosis, and information relating to the one or more drugs, wherein an intravenous pump unit monitors one or more effects of the one or more drugs administered to the patient,

calculates an effectiveness rating for the set drug administration schedule based on the monitored effects, the effectiveness rating indicating the efficacy of the one or more administered drugs and/or extent of improvement in the patient'"'"'s medical condition by the drug administration;

causes display of a user interface allowing a user to update the calculated effectiveness rating; and

updates a patient record for the patient stored in the at least one database based on the monitored effects and calculated or updated effectiveness rating.

9. The system of claim 8, wherein the processor formulates the schedule of drug administration by selecting a drug administration schedule from a plurality of drug administration schedules.

10. The system of claim 9, wherein the processor selects the drug administration schedule based on drug administration schedules previously used for patients with similar medical profiles.

11. The system of claim 8, wherein the one or more drugs are associated with at least one genetic factor.

12. The system of claim 11, wherein the genetic factor includes a circadian gene.

13. The system of claim 8, wherein the processor executes further instructions to modify the set drug administration schedule based on at least one of the pulse oximetry data, one or more observed patient responses to the set drug administration schedule, the calculated effectiveness rating, and an effectiveness rating inputted by a medical personnel.

14. The system of claim 8, wherein the intravenous pump unit can control one or more drug delivery rates, at least one environment parameter, dosing frequency, and amount of drug delivered over the duration of the treatment period.